Stay updated on Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.

Latest updates to the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page
- Check6 days agoChange DetectedRevision history updated to include v3.5.2 and remove v3.5.0.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3 in the Record History.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.1%

- Check70 days agoChange DetectedLatest revision on 2026-02-05 (v3.4.2) adds Returned date, Quality Control Review Has Not Concluded, and new study sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow. It also removes the older government funding notice and the prior revision (v3.4.1).SummaryDifference2%

- Check77 days agoChange DetectedA government funding notice banner was added and the revision label updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check84 days agoChange DetectedThe additions describe UI and versioning details on the history page (Show glossary, Results Submitted, color-coded highlights for additions and deletions, and Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.